- Disease area(s): HIV/AIDS
- Company(ies): Roche
- Partner(s): PharmAccess Foundation
- Since 2001
- Program type(s): Access – Donation, Capacity Building – Training
- Developing country(ies): (28 African countries)
- Contact(s): Contact
- 1014
CARE, the Cohort program to evaluate Access to antiRetroviral treatment and Education, is designed to provide antiretroviral medicines to people living with HIV/AIDS and serve as a model for providing HIV healthcare in resource-limited countries worldwide.
The program was launched in 2001 by PharmAccess Foundation and Roche in four treatment centers in Cote d´Ivoire, Kenya, Senegal and Uganda. Funding, diagnostic and monitoring tests, as well as support for training of healthcare professionals and education for patients, were provided by Roche, which also donated ARVs for use in the program.
Roche and PharmAccess Foundation have since held five CARE training and experience exchange events, which have brought together over 600 healthcare professionals from 28 African countries to discuss HIV/AIDS and share knowledge, to help improve care and treatment, and to develop strategies to overcome challenges. In 2006, a three-day HIV/AIDS education event was organized for over 170 healthcare professionals, focused on African issues. The event gathered over 1,400 insights and comments, providing a unique overview of the needs of Africans and how their perspectives differ from those in the West.
The countries represented at the 5th CARE experience exchange event in Uganda, April 2008 are: Angola, Benin, Botswana, Burkina Faso, Cameroon, Côte d'Ivoire, Democratic Republic of Congo, Ethiopia, Gabon, Ghana, Kenya, Lesotho, Madagascar, Malawi, Mali, Mauritius, Namibia, Nigeria, Rwanda, Senegal, Seychelles, Sierra Leone, South Africa, Tanzania, Togo, Uganda, Zambia and Zimbabwe.

